Multivariate Cox regression further confirmed that high CD146 expression is an independent adverse prognosis factor for ccRCC patients, suggesting that CD146 is a novel prognostic biomarker in ccRCC. The gene discussed is MCAM; the disease is nonpapillary renal cell carcinoma.